All Posts

UF Health among elite group selected to create 3D cellular map of human body

University of Florida Health is one of five institutions nationwide selected by the National Institutes of Health to help create a groundbreaking 3D cellular map of large portions of the human body that may one day transform understanding of diseases, the NIH announced today. UF Health officials describe…

Medical Director is Author on ADA’s Position Statement

https://diabetes.ufl.edu/files/2018/08/Schatz_ADA-Position-Statemet.mp4 Dr. Desmond Schatz, medical director of the UF Diabetes Institute and past president of medicine & science of the American Diabetes Association (ADA), is the senior author of the ADA’s position statement “Type 1 Diabetes in Children and Adolescents”. Read the ADA’s position statement: http://care.diabetesjournals.org/…/ea…/2018/07/19/dci18-0023.

Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction

This study evaluated the effects of dulaglutide vs placebo on liver and glycaemic/metabolic measurements in a population with Type 2 diabetes and in a subgroup with non-alcoholic fatty liver/non-alcoholic steatohepatitis.Once-weekly dulaglutide improved alanine aminotransferase, aspartate transaminase and gamma-glutamyl transpeptidase levels compared with placebo in a pattern consistent with…